ROYAL BANK OF CANADA - ONCONOVA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$030
-3.2%
0.00%
Q1 2018$0310.0%0.00%
Q4 2017$0310.0%0.00%
Q3 2017$031
+3.3%
0.00%
Q2 2017$0300.0%0.00%
Q1 2017$0300.0%0.00%
Q4 2016$0300.0%0.00%
Q3 2016$0
-100.0%
30
-99.9%
0.00%
Q2 2016$170,00029,3920.00%
Other shareholders
ONCONOVA THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
TYNDALL CAPITAL PARTNERS L P 520,832$1,182,00041.42%
Boxer Capital, LLC 316,380$718,0000.28%
SABBY MANAGEMENT, LLC 452,804$1,028,0000.06%
Acrospire Investment Management LLC 4,300$10,0000.00%
Weiss Multi-Strategy Advisers LLC 24,087$55,0000.00%
Hartford Financial Management Inc. 1,100$2,0000.00%
Virtu KCG Holdings LLC 10,883$25,0000.00%
GLENMEDE TRUST CO NA 250$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 77$00.00%
CITIGROUP INC 338$1,0000.00%
View complete list of ONCONOVA THERAPEUTICS INC shareholders